[
  {
    "ts": null,
    "headline": "Healthcare Stocks Are at an Historic Low and a Turnaround Is on the Horizon",
    "summary": "There is a \"for sale\" sign on the sector, and these two stocks look particularly attractive at their current levels.",
    "url": "https://finnhub.io/api/news?id=714f4b95304320cee563c3e0bceb449c365c04b9a7f851021b9bb3fd5b42e10a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758379500,
      "headline": "Healthcare Stocks Are at an Historic Low and a Turnaround Is on the Horizon",
      "id": 136828228,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "There is a \"for sale\" sign on the sector, and these two stocks look particularly attractive at their current levels.",
      "url": "https://finnhub.io/api/news?id=714f4b95304320cee563c3e0bceb449c365c04b9a7f851021b9bb3fd5b42e10a"
    }
  },
  {
    "ts": null,
    "headline": "A Look at Pfizer’s (PFE) Valuation Following Fresh Legal Rulings and Positive COVID Vaccine Trial Data",
    "summary": "If you have been watching Pfizer (PFE) lately, you probably noticed a fresh round of headlines. These include legal developments around its COVID-19 vaccine patents and an antitrust settlement related to generic drug pricing. In addition, upbeat Phase 3 trial data for their next-generation COVID-19 vaccine has focused investor attention on the stock. These events are prompting conversations about the company’s ongoing risks and revenue resilience as it navigates the post-pandemic market...",
    "url": "https://finnhub.io/api/news?id=482f6fa14d98b13be5c83c649660a9d91cfb6b5d8015e5da031b27d94b2ec7e2",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758374359,
      "headline": "A Look at Pfizer’s (PFE) Valuation Following Fresh Legal Rulings and Positive COVID Vaccine Trial Data",
      "id": 136828229,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "If you have been watching Pfizer (PFE) lately, you probably noticed a fresh round of headlines. These include legal developments around its COVID-19 vaccine patents and an antitrust settlement related to generic drug pricing. In addition, upbeat Phase 3 trial data for their next-generation COVID-19 vaccine has focused investor attention on the stock. These events are prompting conversations about the company’s ongoing risks and revenue resilience as it navigates the post-pandemic market...",
      "url": "https://finnhub.io/api/news?id=482f6fa14d98b13be5c83c649660a9d91cfb6b5d8015e5da031b27d94b2ec7e2"
    }
  },
  {
    "ts": null,
    "headline": "What Is Considered a Good Stock Dividend? 3 Healthcare Stocks That Fit the Bill",
    "summary": "A high yield is only one part of the story when it comes to picking dividend stocks.",
    "url": "https://finnhub.io/api/news?id=0292747b921a721c03a99f90903f245a3b821e7d018b34256ca6c00244387122",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758361560,
      "headline": "What Is Considered a Good Stock Dividend? 3 Healthcare Stocks That Fit the Bill",
      "id": 136828152,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "A high yield is only one part of the story when it comes to picking dividend stocks.",
      "url": "https://finnhub.io/api/news?id=0292747b921a721c03a99f90903f245a3b821e7d018b34256ca6c00244387122"
    }
  },
  {
    "ts": null,
    "headline": "Prediction: These Could Be the Best-Performing Value Stocks Through 2030",
    "summary": "These stocks are bargains now. But they probably won't be by the end of this decade.",
    "url": "https://finnhub.io/api/news?id=eabf5259efc02155556180919ff971f43b38a869f0e92c96d32032863fb18b00",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758361440,
      "headline": "Prediction: These Could Be the Best-Performing Value Stocks Through 2030",
      "id": 136828210,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "These stocks are bargains now. But they probably won't be by the end of this decade.",
      "url": "https://finnhub.io/api/news?id=eabf5259efc02155556180919ff971f43b38a869f0e92c96d32032863fb18b00"
    }
  }
]